Transaction · 0001628280-26-011097

Olivo Alicia C

Olivo Alicia C, EVP, GC, BD, reported a transaction classified as withholding at NEOGENOMICS INC involving 3323.000000 shares for an estimated $0.00. Reported holdings after the transaction were 93224.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FEVP, GC, BD
NEONEOGENOMICS INC
Filing timeFeb 24
Trade dateFeb 23, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$9.65
Pre-filing
1mo ago +32.7%1w ago +17.9%1d ago +2.5%
Returns since
7d -1.2%30d -19.6%90d -4.4%180d +76.0%1y +73.6%

NEO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NEO since 2026-02-24Filed 192 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001628280-26-011097
Common Stock
Transaction date
Feb 23, 2026
Filed Feb 24, 2026, 12:00 AM · 1d delay
Shares
3.32k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
93.2k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, GC & Business Development

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

  2. F2

    Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock un…

  3. F3

    On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

  4. F4

    Once vested, the shares of common stock are not subject to expiration.

  5. F5

    On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

  6. F6

    On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.

  7. F7

    On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.

  8. F8

    On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.

  9. F9

    On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.

  10. F10

    On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.

  11. F11

    On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.

  12. F12

    On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date.

  13. F13

    On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

  14. F14

    On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the…

  15. F15

    On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.

  16. F16

    On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to…

  17. F17

    This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.

  18. F18

    On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date.

Original filing · 0001628280-26-011097
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NEO